iBio Inc (AMEX:IBIO)
$ 1.92 -0.062 (-3.13%) Market Cap: 16.56 Mil Enterprise Value: 28.59 Mil PE Ratio: 0 PB Ratio: 0.66 GF Score: 36/100

Ibio Inc at JMP Securities Hematology Oncology Summit (Virtual) Transcript

Dec 07, 2022 / 06:20PM GMT
Release Date Price: $13.48 (-57.88%)
Roy Buchanan
JMP Securities LLC - Analyst

Okay. Thank you, everyone, for joining us again for the virtual JMP Securities Hematology and Oncology Conference. The next company we have with us is iBio Incorporated.

And we have Martin Brenner, DVM and Ph.D. He's the Chief Scientific Officer and currently the co-interim CEO of the company. And we know Martin also from his work at Phoenix, he's clearly done quality science. So thank you for joining us today, Martin.

Martin Brenner
iBio, Inc. - Chief Scientific Officer & Co-Interim CEO

Thank you very much for having me, Roy.

Questions & Answers

Roy Buchanan
JMP Securities LLC - Analyst

All right. Well, let's get started. There's been -- it's been a very exciting time at the company, quite a number of big, big changes. I guess, maybe just describe to us what the current operations look like at the company. You recently acquired company RubrYc, an all-stock deal. Are those operations fully integrated? What's the structure of the company look like

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot